MCK vs ORMP
McKesson Corporation (MCK) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MCK and ORMP stock pages for the full models.
Not investment advice.